The approval process typically involves several stages, including preclinical testing, clinical trials, and post-market surveillance. During preclinical testing, the safety and efficacy of nanomaterials are assessed in vitro and in vivo. If these tests are successful, the product moves on to clinical trials, which are conducted in phases to evaluate its performance in humans. Finally, post-market surveillance ensures ongoing monitoring of the product once it is available to the public.
